Smad linker region phosphorylation in the regulation of extracellular matrix synthesis

Cellular and Molecular Life Sciences

Volumn 68, Issue 1, 2011, Pages 97-107

  Burch, Micah L ^a,b   Zheng, Wenhua ^c   Little, Peter J ^a,b,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c SUN YAT SEN UNIVERSITY   (China)

^d NONE   (Australia)

Author keywords

Collagen; Phosphorylation; Proteoglycans; Signalling; Smads; Transforming growth factor ; Vascular smooth muscle

Indexed keywords

COLLAGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEOGLYCAN; SERINE; SMAD PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

AMINO ACID SEQUENCE; ATHEROSCLEROSIS; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; COLLAGEN SYNTHESIS; DRUG TARGETING; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; INHIBITION KINETICS; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEOGLYCAN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; COLLAGEN; EXTRACELLULAR MATRIX; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEOGLYCANS; RATS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 78650982203     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0514-4     Document Type: Review

References (72)

1. J Massague J Seoane D Wotton 2005 Smad transcription factors Genes Dev 19 2783 2810 1:CAS:528:DC%2BD2MXhtlWqsrnI 10.1101/gad.1350705 16322555 (Pubitemid 41739965)
2. K Wharton R Derynck 2009 TGFbeta family signaling: novel insights in development and disease Development 136 3691 3697 1:CAS:528:DC%2BD1MXhsFyltrrL 10.1242/dev.040584 19855012
3. A Agrotis N Kalinina A Bobik 2005 Transforming growth factor-beta, cell signaling and cardiovascular disorders Curr Vasc Pharmacol 3 55 61 1:CAS:528:DC%2BD2MXhvFOhsg%3D%3D 10.2174/1570161052773951 15638782 (Pubitemid 40089527)
4. SP Evanko EW Raines R Ross LI Gold TN Wight 1998 Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta Am J Pathol 152 533 546 1:CAS:528: DyaK1cXht1Wlt70%3D 9466580
5. B Jian J Xu J Connolly RC Savani N Narula B Liang RJ Levy 2002 Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells Am J Pathol 161 2111 2121 1:CAS:528: DC%2BD38Xpslemurk%3D 12466127
6. D Padua J Massague 2009 Roles of TGFbeta in metastasis Cell Res 19 89 102 1:CAS:528:DC%2BD1MXht1GgsA%3D%3D 10.1038/cr.2008.316 19050696
7. R Derynck YE Zhang 2003 Smad-dependent and Smad-independent pathways in TGF-beta family signalling Nature 425 577 584 1:CAS:528:DC%2BD3sXnvV2hs7c%3D 10.1038/nature02006 14534577 (Pubitemid 37280136)
8. J Massague SW Blain RS Lo 2000 TGFbeta signaling in growth control, cancer, and heritable disorders Cell 103 295 309 1:CAS:528:DC%2BD3cXns1Clt7w%3D 10.1016/S0092-8674(00)00121-5 11057902
9. CH Heldin K Miyazono P ten Dijke 1997 TGF-beta signalling from cell membrane to nucleus through SMAD proteins Nature 390 465 471 1:CAS:528:DyaK2sXnvFyrtLo%3D 10.1038/37284 9393997 (Pubitemid 28013118)
10. P Blume-Jensen T Hunter 2001 Oncogenic kinase signalling Nature 411 355 365 1:CAS:528:DC%2BD3MXktVSjsr0%3D 10.1038/35077225 11357143 (Pubitemid 32467045)
11. J Massague 1998 TGF-beta signal transduction Annu Rev Biochem 67 753 791 1:CAS:528:DyaK1cXlsFOmsbY%3D 10.1146/annurev.biochem.67.1.753 9759503 (Pubitemid 28411144)
12. PA Hoodless T Haerry S Abdollah M Stapleton MB O'Connor L Attisano JL Wrana 1996 MADR1, a MAD-related protein that functions in BMP2 signaling pathways Cell 85 489 500 1:CAS:528:DyaK28XjtFyitrc%3D 10.1016/S0092-8674(00) 81250-7 8653785 (Pubitemid 26157188)
13. F Li B Zeng Y Chai P Cai C Fan T Cheng 2009 The linker region of Smad2 mediates TGF-beta-dependent ERK2-induced collagen synthesis Biochem Biophys Res Commun 386 289 293 1:CAS:528:DC%2BD1MXotFKlsr4%3D 10.1016/j.bbrc.2009.05.084 19465000
14. YK Kim 2007 TGF-beta1 induction of p21WAF1/cip1 requires Smad-independent protein kinase C signaling pathway Arch Pharm Res 30 739 742 1:CAS:528:DC%2BD2sXosV2lt7w%3D 10.1007/BF02977636 17679552
15. MC Cushing PD Mariner JT Liao EA Sims KS Anseth 2008 Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells Faseb J 22 1769 1777 1:CAS:528:DC%2BD1cXnsVKis7w%3D 10.1096/fj.07-087627 18218921 (Pubitemid 351811454)
16. T Tabata K Kokura P Ten Dijke S Ishii 2009 Ski co-repressor complexes maintain the basal repressed state of the TGF-beta target gene, SMAD7, via HDAC3 and PRMT5 Genes Cells 14 17 28 1:CAS:528:DC%2BD1MXpsFagsQ%3D%3D 10.1111/j.1365-2443.2008.01246.x 19032343
17. HC Huang Y Liang LJ Cheng 2004 Transforming growth factor beta 1 modulates connective tissue growth factor expression via Smad2 signaling pathway in podocyte in vitro Zhonghua Yi Xue Za Zhi 84 574 577 1:CAS:528: DC%2BD2MXmsVeltb4%3D 15144593
18. G Wang I Matsuura D He F Liu 2009 Transforming growth factor-{beta}-inducible phosphorylation of Smad3 J Biol Chem 284 9663 9673 1:CAS:528:DC%2BD1MXjvFKkt7k%3D 10.1074/jbc.M809281200 19218245
19. A Moustakas CH Heldin 2009 The regulation of TGFbeta signal transduction Development 136 3699 3714 1:CAS:528:DC%2BD1MXhsFyltrrE 10.1242/dev.030338 19855013
20. L Yang HL Moses 2008 Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer? Cancer Res 68 9107 9111 1:CAS:528:DC%2BD1cXhtlOmt7zP 10.1158/0008-5472.CAN-08-2556 19010878
21. KJ Gordon GC Blobe 2008 Role of transforming growth factor-beta superfamily signaling pathways in human disease Biochim Biophys Acta 1782 197 228 1:CAS:528:DC%2BD1cXjs1Wms7o%3D 18313409
22. P ten Dijke HM Arthur 2007 Extracellular control of TGFbeta signalling in vascular development and disease Nat Rev Mol Cell Biol 8 857 869 1:CAS:528:DC%2BD2sXhtF2qsL3O 10.1038/nrm2262 17895899 (Pubitemid 47622560)
23. A Nakao E Roijer T Imamura S Souchelnytskyi G Stenman CH Heldin P ten Dijke 1997 Identification of Smad2, a human Mad-related protein in the transforming growth factor beta signaling pathway J Biol Chem 272 2896 2900 1:CAS:528:DyaK2sXpslCksQ%3D%3D 10.1074/jbc.272.5.2896 9006934 (Pubitemid 27053339)
24. RH Chen TY Chang 1997 Involvement of caspase family proteases in transforming growth factor-beta-induced apoptosis Cell Growth Differ 8 821 827 1:CAS:528:DyaK2sXksF2msLc%3D 9218876
25. T Itoh T Takenawa 2002 Phosphoinositide-binding domains: functional units for temporal and spatial regulation of intracellular signalling Cell Signal 14 733 743 1:CAS:528:DC%2BD38XktVaqurc%3D 10.1016/S0898-6568(02)00028-1 12034354 (Pubitemid 34597180)
26. M Simonsson M Kanduri E Gronroos CH Heldin J Ericsson 2006 The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation J Biol Chem 281 39870 39880 1:CAS:528:DC%2BD28XhtlCrtrbE 10.1074/jbc.M607868200 17074756 (Pubitemid 46041790)
27. GJ Inman 2005 Linking Smads and transcriptional activation Biochem J 386 e1 e3 1:CAS:528:DC%2BD2MXitVyitLk%3D 10.1042/BJ20042133 15702493
28. K Yoshida K Matsuzaki S Mori Y Tahashi H Yamagata F Furukawa T Seki M Nishizawa J Fujisawa K Okazaki 2005 Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury Am J Pathol 166 1029 1039 1:CAS:528:DC%2BD2MXjsFaks7k%3D 15793284
29. SJ Wicks S Lui N Abdel-Wahab RM Mason A Chantry 2000 Inactivation of Smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II Mol Cell Biol 20 8103 8111 1:CAS:528:DC%2BD3cXnslOjtrw%3D 10.1128/MCB.20.21.8103-8111.2000 11027280
30. M Kretzschmar J Doody I Timokhina J Massague 1999 A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras Genes Dev 13 804 816 1:CAS:528:DyaK1MXisF2isrg%3D 10.1101/gad.13.7.804 10197981
31. M Kretzschmar J Doody J Massague 1997 Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1 Nature 389 618 622 1:CAS:528:DyaK2sXmslWgu7c%3D 10.1038/39348 9335504 (Pubitemid 27446181)
32. M Raman W Chen MH Cobb 2007 Differential regulation and properties of MAPKs Oncogene 26 3100 3112 1:CAS:528:DC%2BD2sXlt1Wkt7o%3D 10.1038/sj.onc. 1210392 17496909 (Pubitemid 46763006)
33. ME Ivey N Osman PJ Little 2008 Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis Atherosclerosis 199 237 247 1:CAS:528:DC%2BD1cXptVWksLs%3D 10.1016/j. atherosclerosis.2008.03.006 18436225
34. AJ Muslin 2008 MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets Clin Sci (Lond) 115 203 218 1:CAS:528:DC%2BD1cXhtVGktLrM 10.1042/CS20070430
35. MK Lee C Pardoux MC Hall PS Lee D Warburton J Qing SM Smith R Derynck 2007 TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA EMBO J 26 3957 3967 1:CAS:528:DC%2BD2sXpvFWhsL0%3D 10.1038/sj.emboj. 7601818 17673906 (Pubitemid 47367487)
36. AJ Galliher-Beckley WP Schiemann 2008 Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta Carcinogenesis 29 244 251 1:CAS:528:DC%2BD1cXislKhtr0%3D 10.1093/carcin/bgm245 18174260 (Pubitemid 351359662)
37. K Yamaguchi K Shirakabe H Shibuya K Irie I Oishi N Ueno T Taniguchi E Nishida K Matsumoto 1995 Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction Science 270 2008 2011 1:CAS:528:DyaK28XltlSl 10.1126/science.270.5244.2008 8533096
38. PJ Little CB Neylon VA Tkachuk A Bobik 1992 Endothelin-1 and endothelin-3 stimulate calcium mobilization by different mechanisms in vascular smooth muscle Biochem Biophys Res Commun 183 694 700 1:CAS:528:DyaK38XhvVylsr8%3D 10.1016/0006-291X(92)90538-V 1550575
39. BC Berk TA Brock MA Gimbrone Jr RW Alexander 1987 Early agonist-mediated ionic events in cultured vascular smooth muscle cells. Calcium mobilization is associated with intracellular acidification J Biol Chem 262 5065 5072 1:CAS:528:DyaL2sXitVynsLc%3D 3031038
40. A Bobik A Grooms JA Millar A Mitchell S Grinpukel 1990 Growth factor activity of endothelin on vascular smooth muscle Am J Physiol 258 C408 C415 1:CAS:528:DyaK3cXhvFaltrc%3D 1690514
41. K Sudhir E Wilson K Chatterjee HE Ives 1993 Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells J Clin Invest 92 3003 3007 1:CAS:528:DyaK2cXks1Grug%3D%3D 10.1172/JCI116923 8254054
42. Y Saito BC Berk 2001 Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors J Mol Cell Cardiol 33 3 7 1:CAS:528:DC%2BD3cXptVygu7s%3D 10.1006/jmcc.2000.1272 11133218 (Pubitemid 32127779)
43. H Daub FU Weiss C Wallasch A Ullrich 1996 Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors Nature 379 557 560 1:CAS:528:DyaK28XhtVWhtr4%3D 10.1038/379557a0 8596637 (Pubitemid 26049585)
44. C Alarcon AI Zaromytidou Q Xi S Gao J Yu S Fujisawa A Barlas AN Miller K Manova-Todorova MJ Macias G Sapkota D Pan J Massague 2009 Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways Cell 139 757 769 1:CAS:528:DC%2BD1MXhsFylsbbJ 10.1016/j.cell.2009.09.035 19914168
45. S Gao C Alarcon G Sapkota S Rahman PY Chen N Goerner MJ Macias H Erdjument-Bromage P Tempst J Massague 2009 Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling Mol Cell 36 457 468 1:CAS:528:DC%2BD1MXhsFOlt7jF 10.1016/j.molcel.2009.09.043 19917253
46. ML Burch SN Yang ML Ballinger R Getachew N Osman PJ Little 2010 TGF-β stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad 2 Cell Mol Life Sci 67 12 2077 2090 1:CAS:528: DC%2BC3cXmsFyru7Y%3D 10.1007/s00018-010-0315-9 20213272
47. ME Ivey PJ Little 2008 Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways. Thromb Res Thromb Res 123 288 297 1:CAS:528:DC%2BD1cXhtlGmtL7O 10.1016/j.thromres.2008.04.019 18571697
48. ML Ballinger ME Ivey N Osman WG Thomas PJ Little 2009 Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL Atherosclerosis 205 451 457 1:CAS:528:DC%2BD1MXptVemu7Y%3D 10.1016/j.atherosclerosis.2009.01.024 19217622
49. H Ungefroren W Lenschow WB Chen F Faendrich H Kalthoff 2003 Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein kinase signaling downstream of Smad signaling J Biol Chem 278 11041 11049 1:CAS:528:DC%2BD3sXit1Kgsrs%3D 10.1074/jbc.M300035200 12538652 (Pubitemid 36792654)
50. J Massague 2003 Integration of Smad and MAPK pathways: a link and a linker revisited Genes Dev 17 2993 2997 1:CAS:528:DC%2BD2cXhs1Siug%3D%3D 10.1101/gad.1167003 14701870 (Pubitemid 38040762)
51. C Itman C Small M Griswold AK Nagaraja MM Matzuk CW Brown DA Jans KL Loveland 2009 Developmentally regulated SMAD2 and SMAD3 utilization directs activin signaling outcomes Dev Dyn 238 1688 1700 1:CAS:528:DC%2BD1MXovV2nu78%3D 10.1002/dvdy.21995 19517569
52. K Lehmann E Janda CE Pierreux M Rytomaa A Schulze M McMahon CS Hill H Beug J Downward 2000 Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells Genes Dev 14 2610 2622 1:CAS:528:DC%2BD3cXnslGru7s%3D 10.1101/gad.181700 11040215
53. L Cai D Fritz L Stefanovic B Stefanovic 2009 Coming together: liver fibrosis, collagen mRNAs and the RNA binding protein Expert Rev Gastroenterol Hepatol 3 1 3 1:CAS:528:DC%2BD1MXhslygs7s%3D 10.1586/17474124.3.1.1 19210106
54. M Ponticos AM Holmes X Shi-wen P Leoni K Khan VS Rajkumar RK Hoyles G Bou-Gharios CM Black CP Denton DJ Abraham A Leask GE Lindahl 2009 Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen Arthritis Rheum 60 2142 2155 1:CAS:528:DC%2BD1MXptlKrsLw%3D 10.1002/art.24620 19565505
55. Van Bruaene N, Derycke L, Perez-Novo CA, Gevaert P, Holtappels G, De Ruyck N, Cuvelier C, Van Cauwenberge P, Bachert C (2009) TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 124, 253-259 (259 e1-2)
56. F Li C Fan T Cheng C Jiang B Zeng 2009 Efficient inhibition of fibroblast proliferation and collagen expression by ERK2 siRNAs Biochem Biophys Res Commun 382 259 263 1:CAS:528:DC%2BD1MXkt1Slurg%3D 10.1016/j.bbrc.2009.02.165 19285964
57. T Hayashida M Decaestecker HW Schnaper 2003 Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells FASEB J 17 1576 1578 1:CAS:528:DC%2BD3sXmtVKnsbs%3D 12824291
58. Y Nakashima TN Wight K Sueishi 2008 Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans Cardiovasc Res 79 14 23 1:CAS:528:DC%2BD1cXnt1Skt74%3D 10.1093/cvr/cvn099 18430750 (Pubitemid 351881944)
59. KJ Williams I Tabas 1995 The response-to-retention hypothesis of early atherogenesis Arterioscler Thromb Vasc Biol 15 551 561 1:STN:280: DyaK2M3mvV2qsQ%3D%3D 7749869
60. I Tabas KJ Williams J Boren 2007 Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications Circulation 116 1832 1844 1:CAS:528:DC%2BD2sXhtFersLnL 10.1161/CIRCULATIONAHA. 106.676890 17938300 (Pubitemid 350287108)
61. PJ Little N Osman KD O'Brien 2008 Hyperelongated biglycan: the surreptitious initiator of atherosclerosis Curr Opin Lipidol 19 448 454 1:CAS:528:DC%2BD1cXhtVOitbbI 10.1097/MOL.0b013e32830dd7c4 18769225
62. J Nigro RJ Dilley PJ Little 2002 Differential effects of gemfibrozil on migration, proliferation and proteoglycan production in human vascular smooth muscle cells Atherosclerosis 162 119 129 1:CAS:528:DC%2BD38Xis1eitrs%3D 10.1016/S0021-9150(01)00704-3 11947905 (Pubitemid 34327349)
63. L Tannock PJ Little TN Wight A Chait 2002 Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced binding to LDL J Lipid Res 43 149 157 1:CAS:528:DC%2BD38XhtFWmtb0%3D 11792734 (Pubitemid 34117229)
64. ML Ballinger J Nigro KV Frontanilla AM Dart PJ Little 2004 Regulation of glycosaminoglycan structure and atherogenesis Cell Mol Life Sci 61 1296 1306 1:CAS:528:DC%2BD2cXlvFSgt70%3D 10.1007/s00018-004-3389-4 15170508 (Pubitemid 38822421)
65. PJ Little ML Ballinger N Osman 2007 Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis Vasc Health Risk Manag 3 1 8
66. Ballinger ML, Osman N, Hashimura K, de Hann J, Jandeleit-Dahm K, Allen TJ, Tannock LR, Rutledge JC, Little PJ (2009) Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo. J Cell Mol Med 14(6):1408-1418
67. AV Finn MC Kramer M Vorpahl FD Kolodgie R Virmani 2009 Pharmacotherapy of coronary atherosclerosis Expert Opin Pharmacother 10 1587 1603 1:CAS:528:DC%2BD1MXnt1Ortbs%3D 10.1517/14656560902988494 19527187
68. PJ Little L Tannock KL Olin A Chait TN Wight 2002 Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs Arterioscler Thromb Vasc Biol 22 55 60 1:CAS:528:DC%2BD38XmslOjtA%3D%3D 10.1161/hq0102.101100 11788461 (Pubitemid 34076232)
69. H Dadlani ML Ballinger N Osman R Getachew PJ Little 2008 Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle J Biol Chem 283 7844 7852 1:CAS:528:DC%2BD1cXjt1elsLg%3D 10.1074/jbc.M703125200 18223258
70. H Watanabe MP de Caestecker Y Yamada 2001 Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells J Biol Chem 276 14466 14473 1:CAS:528: DC%2BD3MXjt12rtLc%3D 11278290
71. PJ Little ML Ballinger ML Burch N Osman 2008 Biosynthesis of natural and hyperelongated chondroitin sulfate glycosaminoglycans: new insights into an elusive process Open Biochem J 2 135 142 1:CAS:528:DC%2BD1MXmsFOr 10.2174/1874091X00802010135 19238187
72. SN Yang ML Burch R Getachew ML Ballinger N Osman PJ Little 2009 Growth factor-mediated hyper-elongation of glycosaminoglycan chains on biglycan requires transcription and translation Arch Physiol Biochem 115 147 154 1:CAS:528:DC%2BD1MXhtFSqu77L 10.1080/13813450903110754 19580379